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Background/aim: The current study was carried out to describe the clinical presentation, antimicrobial susceptibility pattern, and
outcome of invasive nontyphoidal Salmonella disease (iNTS) in a tertiary care center.
Materials and methods: A 5-year hospital-based retrospective study was carried out on blood culture-confirmed cases of iNTS. Medical
records of patients were reviewed to obtain information on demography, clinical manifestations, comorbidities, complications, immune
status, treatment, and clinical outcome.
Results: A total of 40 blood culture-confirmed cases of iNTS were diagnosed during the study period. Among these 40 isolates, 9
(22.5%) were identified as Salmonella Typhimurium. Fever (67.5%) with gastrointestinal disturbance (40%) was the most common
clinical presentation. The majority of the patients were immunosuppressed (75%). All isolates were susceptible to all the antimicrobials
tested. Ceftriaxone (92.5%) was the most common antimicrobial used in our setting. A total of 15% patients died during the hospital
stay.
Conclusion: We conclude that iNTS disease is a severe infection prevailing in India with a high mortality rate. Anemia and diabetes
were the two most common comorbidities. Though all NTS organisms isolated were sensitive to all the antimicrobials tested, we suggest
that continued surveillance is necessary to monitor the presence of multidrug-resistant strains.
Key words: Nontyphoidal Salmonella, bacteremia, mortality, extraintestinal infection

1. Introduction
Nontyphoidal salmonellae (NTS) are an important cause
of foodborne gastroenteritis worldwide (1), but bacteremia
and other invasive diseases caused by these organisms
have not been thoroughly explored. The increasing
centralization and industrialization of our food supply have
enhanced the spread of these organisms. Contamination
of varied food products, including poultry, beef, pork,
eggs, milk, cheese, fish, shellfish, vegetables, and fresh fruit
and juice, is the main vehicle for transmitting the disease
to humans (2). In high-income countries, Salmonella
generally causes a self-limiting diarrheal disease in
immunocompetent people; bloodstream or other invasive
infections are rare and are mainly associated with specific
underlying conditions (1). In low-income countries, such
as in sub-Saharan Africa, NTS are consistently the most
common bacterial bloodstream isolates in both adults

and children, specifically in patients with HIV infection
(3–7). Bacteremia due to NTS was first noticed in 1987
in children suffering from malaria (1). Later, a variety of
risk factors were identified in both children and adults,
including infection with HIV, malaria, malnutrition, and
anemia. The clinical presentation of invasive nontyphoidal
Salmonella (iNTS) infection is typically febrile systemic
illness resembling enteric fever. Fever with pneumonia,
diarrhea, and hepatosplenomegaly are the most common
clinical presentations found in African studies (3–5). The
mortality rate is also very high (22%–47%) (8).
In Asia, the epidemiology and clinical manifestations
of iNTS disease are not well documented. Diarrhea is
the third leading cause of childhood mortality (13% of
all deaths/year) in India (9). Due to its high endemicity,
typhoid fever has gained attention, whereas NTS
strains are always considered to be a causative agent of
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diarrheal diseases. The ability of NTS strains to cause
invasive infections has mostly been neglected and poorly
documented. Therefore, we aimed to investigate the
clinical and microbiological manifestations of iNTS in a
tertiary care hospital in southern India.
2. Materials and methods
A 5-year hospital-based retrospective study was carried
out on the culture-confirmed cases of bacteremia caused
by NTS at a tertiary care teaching hospital in southern
India between January 2012 and December 2016. Medical
records of patients were reviewed to obtain information on
demography, clinical manifestations, predisposing factors,
complications, immune status, antibiotic susceptibilities,
treatment, and clinical outcome. Diagnosis of infection
was done by blood culture using the BacT/ALERT 3D
system (BioMérieux, India). Cultures from other sites were
done according to the clinical requirements of patients.
Organisms were presumptively identified as Salmonella
spp. when they showed nonlactose fermenting colonies;
were negative for oxidase, indole, and urease; were positive
for glucose and mannitol fermentation; and showed lysine
decarboxylase and characteristic features on triple sugar
iron agar (glucose fermentation, gas, and H2S). These were
tested for agglutination with Salmonella polyvalent “O”
(Poly A–I & Vi, Cat No. 222641) and polyvalent “H” (Poly
–a–z, Cat No. 224061) antisera (Difco, Becton Dickinson).
Furthermore, isolates that were confirmed as Salmonella
spp. and negative for agglutination by Salmonella Typhi
(Salmonella agglutinating serum 9-O and d-H) and S.
Paratyphi A (Salmonella agglutinating serum 2-O and
a-H) specific antisera, but + for gas production and ±
citrate utilization, were tested with specific antisera for
Salmonella Typhimurium (Salmonella agglutinating serum
4-O and i-H). Isolates that serologically tested negative
for S. Typhimurium but were positive for the genus
Salmonella were grouped as nontyphoidal Salmonella.
Antimicrobial susceptibility testing was performed using
the Kirby–Bauer disk diffusion susceptibility test following
the standard CLSI guidelines (10). All isolates were tested
with ampicillin, chloramphenicol, sulfamethoxazole–
trimethoprim, ciprofloxacin, and ceftriaxone antimicrobial
disks. Interpretative standards for Salmonella spp. were
used for reading ciprofloxacin results.
2.1. Ethics statement
This study was approved by the institutional ethics
committee of Kasturba Hospital, Manipal. This was a
retrospective study with routine anonymous laboratory
and clinical data; individual patient identities were not
accessed and hence informed consent was not required.
2.2. Statistical analysis
All patient information was documented in a study
proforma, which was further digitized, and data analyses

were performed using SPSS 15.0 (SPSS Inc., USA).
Quantitative variables are described as means with standard
deviations and medians with interquartile ranges (IQRs).
Clinical and laboratory data were compared between
groups using Fisher’s exact test or Mann–Whitney U tests
for the categorical and continuous variables, respectively.
3. Results
During the study period, among 78,238 blood cultures, the
incidence of isolation of Salmonella spp. was 0.5, 0.4, and
0.1 per 100 blood cultures for S. Typhi, S. Paratyphi A, and
NTS, respectively. NTS represented 6% of all salmonellae
from cases of bacteremia, while S. Typhi and S. Paratyphi
A were attributed to 52% and 42%.
A total of 40 blood culture-confirmed cases of iNTS
were diagnosed during the study period. The majority
of the patients were male (31, 77.5%). Mean age of the
patients was 47.3 ± 19 years. Table 1 describes the basic
demographics, clinical features, and coinfections among
patients diagnosed with iNTS. Fever (27, 67.5%) with
gastrointestinal disturbances (16, 40%) was the most
common clinical feature found among the patients. The
duration of illness prior to hospital admission was a median
of 3 days (IQR: 2–7 days). The majority of the patients were
immunosuppressed (20/40, 50%) due to various causes;
14 out of 20 patients (70%) were on immunosuppressive
therapy, including steroids, radiation therapy, and
antiretroviral therapy (ART). An additional 25% of
patients had diabetes mellitus. Detailed descriptions of the
duration of hospital stay, time to diagnosis, comorbidity,
complications, and laboratory findings are tabulated below
(Table 2). Laboratory findings were mostly within the
normal ranges. Liver enzymes were elevated in 11 (27.5%)
patients. Abnormal renal function tests were observed
among 17 (42.5%) patients.
The mean time to detection of the pathogen in blood
culture was 2.15 days ± 0.92 days. Among 40 NTS isolates,
only 9 were identified as S. Typhimurium using specific
antisera due to limited availability of agglutinating sera
at the local facility. Acute gastroenteritis was observed
in 16 patients; among these, a stool specimen for culture
was obtained for only 10 patients, but none yielded NTS.
Furthermore, 4/40 (10%) patients were also diagnosed
with LRTI; 2 Klebsiella pneumoniae, 1 Escherichia coli, and
1 Enterobacter cloacae were isolated from their respiratory
specimens. All NTS isolates were susceptible to ampicillin,
chloramphenicol,
sulfamethoxazole–trimethoprim,
ciprofloxacin, and ceftriaxone. Acute kidney injury
(AKI) was the most common (25%) complication of NTS
bacteremia observed in our study cohort. One among
these cases, 10 had yielded NTS from urine in addition to
bacteremia. Three of the patients with AKI had diabetes
mellitus as a comorbidity.
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Table 1. Basic demographics, clinical features, and coinfections
among the patients diagnosed with invasive nontyphoidal
Salmonella.
Variable
Age group
<18
18–30
31–60
>60
Sex
Male
Female

n (%)
3 (7.5)
4 (10)
22 (55)
11 (27.5)
31 (77.5)
9 (22.5)

Clinical presentations
Fever
Acute gastroenteritis
Abdominal pain
Sepsis
Headache
Altered sensorium
Seizure
Encephalitis
Other neurological symptoms

27 (67.5)
16 (40)
10 (25)
10 (25)
6 (15)
5 (12.5)
3 (7.5)
3 (7.5)
8 (20)

Coinfections
HIV infection
Pulmonary tuberculosis
Bacterial pneumonia
Urinary tract infection
Hepatitis C infection

4 (10)
3 (7.5)
3 (7.5)
3 (7.5)
1 (2.5)

Laboratory parameters
Total leucocyte count (×103 /µL)
Hemoglobin (g/dL)
Aspartate amino transferase (IU/L)
Alanine transaminase (IU/L)
Alkaline phosphatase (U/L)

Median (IQR)
10.2 (4.8–15.4)
11.4 (8.8–13.8)
35 (21–60.7)
21 (16–45)
89 (60–151)

A total of 39 (97.5%) patients received empirical
therapy (Table 3). Among them, 28 (71.8%) patients
received at least one drug that is active against Salmonella
spp. Median time to administration of first empirical
therapy was 1 day (IQR: 0–1 day). The majority of iNTS
patients received a disease-specific antimicrobial treatment
(27/40; 67.5%) (Table 3). The most commonly prescribed
antimicrobial was ceftriaxone; 25 (92.5%) patients received
it as mono- or combination therapy. Ceftriaxone was
given to 14 (35.9%) patients and it was continued after the
diagnosis was made. Once the blood culture was reported,
empirical therapy was changed to ceftriaxone for another
11 patients. Overall, 26/40 (65%) patients improved before
hospital discharge, 8 (20%) patients were discharged
against medical advice, and 6 (15%) patients died.
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4. Discussion
Invasive NTS infections are a significant cause of
morbidity and mortality worldwide, but iNTS cases are
rarely reported from India. In this study, we identified
40 blood culture-confirmed cases of iNTS over a period
of 5 years. A systematic review from sub-Saharan Africa
showed that 39% of community-acquired bloodstream
infections were due to NTS pathogens, with a case fatality
rate of 19% (2,3). Due to the lack of reports, the true
burden of iNTS infection in Asia is unclear. A study from
southern Vietnam identified more than 100 cases of iNTS
infection in their setting (11). In Africa, both children and
adults are equally affected by invasive NTS infection (2,3).
In our setting, the majority of our patients were adults and
belonged to the age group of ≥50 years. Similar findings
were observed in the study from Vietnam (11). The clinical
presentation was more or less similar in all of the studies.
All NTS infections start with an episode of gastroenteritis
and then enter the bloodstream after invading the
intestinal barrier. The common risk factors for bacteremia
by NTS are extremes of age, HIV infection, malignancy,
diabetes, autoimmune disorders, and immunosuppressive
therapy (11–18). Dysregulated cytokine production,
depletion of CD4 T-cells and especially interleukin-17producing T cells (Th17 cells), and impaired serum killing
of NTS strains were three important defects found in HIVinfected individuals with invasive NTS infection (19–21).
In children, malnutrition, anemia, and malaria were found
to be important risk factors. Macrophage dysfunction and
cytokine dysregulation in severe malaria and homozygosity
for sickle-cell anemia were found to be important defects
associated with invasive NTS infection (22,23).
In low- and middle-income countries, malnutrition,
anemia, and HIV infection are the most common
predisposing factors for iNTS infections (2–5). As in
African countries, in Vietnam, HIV infection is the
primary risk factor for iNTS in adults (11), while only
10% of our patients were infected with HIV. In our study,
the important comorbidities were found to be anemia
(30%) and type II diabetes mellitus (25%). AKI was the
predominant complication observed here. Although the
underlying mechanisms are unclear, AKI is a well-known
complication of salmonellosis, as reported by many studies
(24–31).
India is a well-known endemic country for enteric
fever and gastroenteritis. Typhoidal serovars are known
to cause systemic infections, and nontyphoidal serovars
of Salmonella are strongly associated with gastroenteritis.
Therefore, the ability of NTS to cause invasive infections
is neglected in this country. The zero fecal-isolation rate
of NTS in our study is speculated to be due to either delay
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Table 2. Duration of hospital stay, time to diagnosis, comorbidity, complications, and laboratory findings among patients who
improved or deteriorated during hospital stay.

Variable

Total
n = 40

Median duration of hospital stay, days

Outcome

P-value

Improved
n = 26 (65%)

Deteriorated
n = 14 (35%)

6.5
(IQR: 4–13)

10
(IQR: 4–17)

3.5
(IQR: 1–5.25)

<0.001

Mean time to diagnosis, days

4.05 ± 1.8

4.04 ± 1.9

4.07 ± 1.5

0.937

Comorbidities
Anemia
Hypertension
Type 2 diabetes mellitus
Malignancy
Chronic kidney disease
Chronic liver disease
HIV infection

25 (62.5)
12 (30)
10 (25)
8 (20)
4 (10)
4 (10)
4 (10)

15 (57.7)
8 (30.8)
5 (19.2)
5 (19.2)
2 (7.7)
1 (3.8)
4 (15.4)

10 (71.4)
4 (28.6)
5 (35.7)
3 (21.4)
2 (14.3)
3 (21.4)
0 (0)

0.307
0.59
0.17
0.588
0.62
0.17
0.164

Complications
Acute kidney injury
Septic shock
Encephalopathy
Nephropathy
Pericarditis
Polyarthritis
Colitis
Pancreatitis
Massive gastrointestinal bleeding

10 (25)
6 (15)
8 (20)
4 (10)
1 (2.5)
1 (2.5)
1 (2.5)
2 (5)
1 (2.5)

6 (23)
5 (19.2)
5 (19.2)
4 (15.4)
1 (3.8)
0 (0)
0 (0)
1 (3.8)
1 (3.8)

4 (28.6)
1 (7.1)
3 (21.4)
0 (0)
0 (0)
1 (7.1)
1 (7.1)
1 (7.1)
0 (0)

0.492
0.115
0.65
0.164
0.65
0.65
0.35
0.583
0.35

Empirical treatment
Ceftriaxone
Piperacillin–tazobactam
Ciprofloxacin/levofloxacin
Amoxicillin–clavulanic acid
Cefoperazone–sulbactam
Meropenem
Sulfamethoxazole–trimethoprim
Ampicillin

14 (35)
10 (25)
5 (12.5)
3 (7.5)
3 (7.5)
2 (5)
1 (2.5)
1 (2.5)

12 (46.2)
4 (15.4)
4 (15.4)
3 (11.5)
1 (3.8)
1 (3.8)
1 (3.8)
0 (0)

2 (14.3)
6 (42.8)
1 (7.1)
0 (0)
2 (14.3)
1 (7.1)
0 (0)
1 (7.1)

Table 3: Details of antimicrobial treatment given to iNTS patients
Disease specific treatment

No. of cases (%) Median duration of treatment in days Outcome

Ceftriaxone
Ceftriaxone +Azithromycin
Ceftriaxone + Sulfamethoxazole-Trimethoprim
Ciprofloxacin
Cefoperazone sulbactam

19 (67.8)
5 (46.2)
1 (3.8)
1 (3.5)
1 (3.5)

in culture requests or early antimicrobial administration.
All the patients who presented with gastroenteritis also
had severe clinical presentations, which directed the
attention of the practitioners towards the practice of blood

7 (R: 4-15)
14 (R: 4-21)
7
7
1

Improved
Improved
Improved
Improved
Died

culture and delay in obtaining fecal specimens. In limited
resource settings, where identification of bacterial isolates
depends on conventional biochemical tests, unavailability
of specific antisera can lead to misdiagnosis of NTS. A few
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case reports from various parts of India described NTS
causing bacteremia in both immunocompromised and
immunocompetent individuals (32–36). Bacteremia due
to NTS is a significant cause of morbidity and mortality
worldwide. We have observed a higher mortality rate
(15%) among immunocompromised individuals than that
observed in Vietnam.
S. Typhimurium is the most commonly identified
serovar globally associated with iNTS infections, followed
by S. Enteritidis. The limited number of S. Typhimurium
infections reported here might be an underestimate,
as antisera were not available for identification of all of
the isolates. Fortunately, all our isolates were sensitive
to all of the antibiotics tested. In other parts of India, a
high percentage of resistance has been observed against
commonly used antibiotics (36). In sub-Saharan countries,
a large number of isolates were resistant to three or more
antibiotics (37), and a multidrug-resistant (MDR) distinct
genotype variant of S. Typhimurium (ST313) has also
emerged (38). In Vietnam, the majority of S. Typhimurium
strains showed high resistance against a variety of

antimicrobials, including ampicillin, chloramphenicol,
sulfamethoxazole–trimethoprim, and ciprofloxacin (11).
In the United States, NTS strains isolated from blood are
most commonly resistant to tetracycline (39). Ceftriaxoneresistant isolates have also been detected in the United
States and Bangladesh (39,40).
We acknowledge a few study limitations. Due to the
retrospective nature of the study, we could not elicit histories
of possible exposure. Furthermore, due to the limited
number of cases, we could not identify the associated risk
factors. Serological identification of all the isolates could
not be done due to the limited availability of antisera.
In conclusion, iNTS is a potential cause of communityacquired bloodstream infection in southern India, with
high morbidity and mortality. Although all NTS organisms
isolated in this study were sensitive to all the antimicrobials
tested, we suggest that continued surveillance is required to
monitor for the presence or introduction of MDR strains.
In this context, it is important to know the actual incidence
of iNTS in India for the development of effective prevention
and control strategies.
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